JAG1 Gene: History
View Latest Version
Please note this is an old version of this entry, which may differ significantly from the current revision.
Subjects: Genetics & Heredity
Contributor:
Dean Liu

Jagged 1

  • genes

1. Introduction

The JAG1 gene provides instructions for making a protein called Jagged-1, which is involved in an important pathway by which cells can signal to each other. The Jagged-1 protein is inserted into the membranes of certain cells. It connects with other proteins called Notch receptors, which are bound to the membranes of adjacent cells. These proteins fit together like a lock and its key. When a connection is made between the Jagged-1 and Notch proteins, it launches a series of signaling reactions (Notch signaling) affecting cell functions. Notch signaling controls how certain types of cells develop in a growing embryo, especially cells destined to be part of the heart, liver, eyes, ears, and spinal column. The Jagged-1 protein continues to play a role throughout life in the development of new blood cells.

2. Health Conditions Related to Genetic Changes

2.1. Alagille Syndrome

At least 226 mutations in the JAG1 gene have been identified in people with Alagille syndrome. Most of these mutations result in an abnormally short Jagged-1 protein that is missing the segment that normally spans the cell membrane (the transmembrane domain). Other mutations interfere with proper transport (trafficking) of the protein within the cell, preventing it from reaching the cell membrane. The loss of Jagged-1 protein at the cell membrane precludes its interaction with Notch proteins and prevents cell signaling. The lack of Notch signaling causes errors in development that result in missing or narrowed bile ducts in the liver, heart defects, distinctive facial features, and changes in other parts of the body. People with JAG1 gene mutations may have one or more of these problems. In particular, some affected individuals have a particular combination of heart defects known as tetralogy of Fallot without other signs or symptoms of Alagille syndrome. The type and severity of problems associated with Alagille syndrome may differ even within the same family.

2.2. Cancers

Increased activity (expression) of the JAG1 gene has been linked to certain cancers, including breast cancer and head and neck tumors. The increased expression of the JAG1 gene may promote the development of new blood vessels that nourish a growing tumor. The altered gene expression may also enhance other cancer-related events such as cell division (proliferation) and the inflammatory response.

3. Other Names for This Gene

  • AGS

  • AHD

  • AWS

  • CD339

  • CD339 antigen

  • HJ1

  • JAG1_HUMAN

  • jagged 1 (Alagille syndrome)

  • jagged 1 precursor

  • JAGL1

This entry is adapted from the peer-reviewed paper https://medlineplus.gov/genetics/gene/jag1

References

  1. Boyer-Di Ponio J, Wright-Crosnier C, Groyer-Picard MT, Driancourt C, Beau I,Hadchouel M, Meunier-Rotival M. Biological function of mutant forms of JAGGED1proteins in Alagille syndrome: inhibitory effect on Notch signaling. Hum MolGenet. 2007 Nov 15;16(22):2683-92.
  2. Colliton RP, Bason L, Lu FM, Piccoli DA, Krantz ID, Spinner NB. Mutationanalysis of Jagged1 (JAG1) in Alagille syndrome patients. Hum Mutat. 2001Feb;17(2):151-2.
  3. Dufraine J, Funahashi Y, Kitajewski J. Notch signaling regulates tumorangiogenesis by diverse mechanisms. Oncogene. 2008 Sep 1;27(38):5132-7. doi:10.1038/onc.2008.227. Review.
  4. Guarnaccia C, Dhir S, Pintar A, Pongor S. The tetralogy of Fallot-associatedG274D mutation impairs folding of the second epidermal growth factor repeat inJagged-1. FEBS J. 2009 Nov;276(21):6247-57. doi:10.1111/j.1742-4658.2009.07333.x.
  5. Kamath BM, Bason L, Piccoli DA, Krantz ID, Spinner NB. Consequences of JAG1mutations. J Med Genet. 2003 Dec;40(12):891-5.
  6. Kim BJ, Fulton AB. The genetics and ocular findings of Alagille syndrome.Semin Ophthalmol. 2007 Oct-Dec;22(4):205-10. Review.
  7. Lu F, Morrissette JJ, Spinner NB. Conditional JAG1 mutation shows thedeveloping heart is more sensitive than developing liver to JAG1 dosage. Am J HumGenet. 2003 Apr;72(4):1065-70.
  8. McElhinney DB, Krantz ID, Bason L, Piccoli DA, Emerick KM, Spinner NB,Goldmuntz E. Analysis of cardiovascular phenotype and genotype-phenotypecorrelation in individuals with a JAG1 mutation and/or Alagille syndrome.Circulation. 2002 Nov 12;106(20):2567-74.
  9. Morrissette JD, Colliton RP, Spinner NB. Defective intracellular transport andprocessing of JAG1 missense mutations in Alagille syndrome. Hum Mol Genet. 2001Feb 15;10(4):405-13.
  10. Piccoli DA, Spinner NB. Alagille syndrome and the Jagged1 gene. Semin LiverDis. 2001 Nov;21(4):525-34. Review.
  11. Spinner NB, Colliton RP, Crosnier C, Krantz ID, Hadchouel M, Meunier-RotivalM. Jagged1 mutations in alagille syndrome. Hum Mutat. 2001;17(1):18-33. Review.
  12. Spinner NB, Gilbert MA, Loomes KM, Krantz ID. Alagille Syndrome. 2000 May 19[updated 2019 Dec 12]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): Universityof Washington, Seattle; 1993-2020. Available fromhttp://www.ncbi.nlm.nih.gov/books/NBK1273/
More
©Text is available under the terms and conditions of the Creative Commons-Attribution ShareAlike (CC BY-SA) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
This entry is offline, you can click here to edit this entry!
Video Production Service
Feedback